Ronny Nienhold

3.0k total citations · 2 hit papers
19 papers, 1.8k citations indexed

About

Ronny Nienhold is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Ronny Nienhold has authored 19 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 5 papers in Molecular Biology and 5 papers in Hematology. Recurrent topics in Ronny Nienhold's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Acute Myeloid Leukemia Research (5 papers) and Eosinophilic Disorders and Syndromes (4 papers). Ronny Nienhold is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Acute Myeloid Leukemia Research (5 papers) and Eosinophilic Disorders and Syndromes (4 papers). Ronny Nienhold collaborates with scholars based in Switzerland, United States and Austria. Ronny Nienhold's co-authors include Kirsten D. Mertz, Alexandar Tzankov, Gieri Cathomas, Markus Tolnay, Jasmin D. Haslbauer, Niels Willi, Thomas Menter, Stephan Frank, Nikolaus Deigendesch and Daniel Turek and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Ronny Nienhold

18 papers receiving 1.8k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction

2020 834 citations Thomas Menter, Jasmin D. Haslbauer et al. Histopathology profile →
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms

2014 401 citations Pontus Lundberg, Axel Karow et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ronny Nienhold Switzerland	12	862	524	510	484	436	19	1.8k
Nongnuch Sirachainan Thailand	22	176 0.2×	99 0.2×	551 1.1×	835 1.7×	260 0.6×	136	1.6k
Barbara Seitz‐Polski France	22	265 0.3×	112 0.2×	204 0.4×	207 0.4×	290 0.7×	62	2.2k
Alessandro Tomelleri Italy	21	453 0.5×	286 0.5×	192 0.4×	60 0.1×	191 0.4×	84	1.4k
Heesun J. Rogers United States	19	165 0.2×	81 0.2×	432 0.8×	497 1.0×	237 0.5×	69	1.2k
Fleur Cohen‐Aubart France	30	776 0.9×	118 0.2×	269 0.5×	140 0.3×	385 0.9×	117	3.1k
Suthesh Sivapalaratnam United Kingdom	15	307 0.4×	153 0.3×	63 0.1×	280 0.6×	228 0.5×	29	1.1k
Elena Baldissera Italy	23	305 0.4×	241 0.5×	110 0.2×	274 0.6×	357 0.8×	65	2.0k
Charlotte Thålin Sweden	18	595 0.7×	437 0.8×	46 0.1×	170 0.4×	522 1.2×	46	2.0k
Ulla M. Saarinen‐Pihkala Finland	26	166 0.2×	131 0.3×	127 0.2×	669 1.4×	397 0.9×	83	2.2k
Akio Mimori Japan	28	171 0.2×	171 0.3×	195 0.4×	399 0.8×	233 0.5×	117	2.1k

Countries citing papers authored by Ronny Nienhold

Since Specialization

Citations

This map shows the geographic impact of Ronny Nienhold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronny Nienhold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronny Nienhold more than expected).

Fields of papers citing papers by Ronny Nienhold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronny Nienhold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronny Nienhold. The network helps show where Ronny Nienhold may publish in the future.

Co-authorship network of co-authors of Ronny Nienhold

This figure shows the co-authorship network connecting the top 25 collaborators of Ronny Nienhold. A scholar is included among the top collaborators of Ronny Nienhold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronny Nienhold. Ronny Nienhold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Christinat, Yann, Baptiste Hamelin, Ilaria Alborelli, et al.. (2024). Reporting of somatic variants in clinical cancer care: recommendations of the Swiss Society of Molecular Pathology. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 485(6). 1033–1039.

Paz, Damien Luque, Ronny Nienhold, Shivam Rai, et al.. (2023). Impact of Clonal Architecture on Clinical Course and Prognosis in Patients With Myeloproliferative Neoplasms. HemaSphere. 7(5). e885–e885. 5 indexed citations

Nienhold, Ronny, Angela Frank, Nathalie Schwab, et al.. (2022). Unbiased screen for pathogens in human paraffin-embedded tissue samples by whole genome sequencing and metagenomics. Frontiers in Cellular and Infection Microbiology. 12. 968135–968135. 7 indexed citations

Schwab, Nathalie, Ronny Nienhold, Maurice Henkel, et al.. (2022). COVID-19 Autopsies Reveal Underreporting of SARS-CoV-2 Infection and Scarcity of Co-infections. Frontiers in Medicine. 9. 868954–868954. 11 indexed citations

Sobottka, Bettina, Ronny Nienhold, Juergen Hench, et al.. (2022). Integrated Analysis Of Immunotherapy Treated Clear Cell Renal Cell Carcinomas: An Exploratory Study. Zurich Open Repository and Archive (University of Zurich). 5 indexed citations

Nienhold, Ronny, et al.. (2021). Combined Simplified Molecular Classification of Gastric Adenocarcinoma, Enhanced by Lymph Node Status: An Integrative Approach. Cancers. 13(15). 3722–3722. 7 indexed citations

Haslbauer, Jasmin D., Alexandar Tzankov, Kirsten D. Mertz, et al.. (2021). Characterisation of cardiac pathology in 23 autopsies of lethal COVID‐19. The Journal of Pathology Clinical Research. 7(4). 326–337. 26 indexed citations

Menter, Thomas, Jasmin D. Haslbauer, Ronny Nienhold, et al.. (2020). Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 77(2). 198–209. 834 indexed citations breakdown →

Nienhold, Ronny, Yari Ciani, Viktor H. Koelzer, et al.. (2020). Two distinct immunopathological profiles in autopsy lungs of COVID-19. Nature Communications. 11(1). 5086–5086. 171 indexed citations

10.

Deigendesch, Nikolaus, Sven Wischnewski, Jürgen Hench, et al.. (2020). Correlates of critical illness-related encephalopathy predominate postmortem COVID-19 neuropathology. Acta Neuropathologica. 140(4). 583–586. 84 indexed citations

11.

Koessler, Thibaud, Salvatore Piscuoglio, Ronny Nienhold, et al.. (2020). Reliability of liquid biopsy analysis: an inter-laboratory comparison of circulating tumor DNA extraction and sequencing with different platforms. Laboratory Investigation. 100(11). 1475–1484. 15 indexed citations

12.

Zmajkovic, Jakub, Pontus Lundberg, Ronny Nienhold, et al.. (2018). A Gain-of-Function Mutation in EPO in Familial Erythrocytosis. New England Journal of Medicine. 378(10). 924–930. 36 indexed citations

13.

Drexler, Beatrice, Jakob Passweg, Alexandar Tzankov, et al.. (2018). The sympathomimetic agonist mirabegron did not lower JAK2-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative neoplasms: results of phase II study SAKK 33/14. Haematologica. 104(4). 710–716. 23 indexed citations

14.

Shimizu, Takafumi, Lucia Kubovčáková, Ronny Nienhold, et al.. (2016). Loss of Ezh2 synergizes with JAK2 -V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis. The Journal of Experimental Medicine. 213(8). 1479–1496. 82 indexed citations

15.

Leković, Danijela, Mirjana Gotić, Radek C. Skoda, et al.. (2016). Bone marrow microvessel density and plasma angiogenic factors in myeloproliferative neoplasms: clinicopathological and molecular correlations. Annals of Hematology. 96(3). 393–404. 17 indexed citations

16.

Pastor, Victoria, Shinsuke Hirabayashi, Axel Karow, et al.. (2016). Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants. Leukemia. 31(3). 759–762. 55 indexed citations

17.

Ajtić, Olivera Mitrović, Bojana Beleslin‐Čokić, Ronny Nienhold, et al.. (2016). Angiogenic factors are increased in circulating granulocytes and CD34⁺ cells of myeloproliferative neoplasms. Molecular Carcinogenesis. 56(2). 567–579. 11 indexed citations

18.

Shimizu, Takafumi, Hui Hao-Shen, Lucia Kubovčáková, et al.. (2014). JAK2V617F and Loss of Ezh2 in Hematopoietic Cells Contribute Synergistically to Myeloproliferative Neoplasm Initiation Potential, and Accelerate Progression of Disease. Blood. 124(21). 158–158. 1 indexed citations

19.

Lundberg, Pontus, Axel Karow, Ronny Nienhold, et al.. (2014). Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood. 123(14). 2220–2228. 401 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact